15 regions chosen for groundbreaking effort to reduce cardiovascular disease [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Cardiovascular-Kidney-Metabolic Health Initiative(TM), designed to improve treatment of the interconnected conditions that lead to heart disease and stroke. The initiative began with five regions in February and has now expanded to include the final 10 regions. The regions include states, cities and metro areas. The initiative, supported by founding sponsors Novo Nordisk and Boehringer Ingelheim, supporting sponsor Novartis Pharmaceuticals Corporation and champion sponsor DaVita, will enroll 150 health care sites across the 15 regions, impacting the care of more than a quarter-million patients. It was created to increase awareness, screening and treatment for a combination of conditions known as cardiovascular-kidney-metabolic (CKM) syndrome . Healthcare organizations who join the initiative will be recognized as " CKM Health Groundbreakers The American Heart Association, a global force changing the future of health for all, defines CKM syndrome as the combined health effects of h
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- GLP-1 Drugs Quietly Reshape How Americans Shop for Food, Study Finds [Yahoo! Finance]Yahoo! Finance
- Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways [Yahoo! Finance]Yahoo! Finance
- Should You Invest in Ozempic Maker Novo Nordisk in 2026? [Yahoo! Finance]Yahoo! Finance
- Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access [Yahoo! Finance]Yahoo! Finance
- Health care will get more expensive for some in 2026 — and cheaper for others [MSNBC.com]MSNBC.com
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website